Feedback loop in miR-449b-3p/ADAM17/NF-κB promotes metastasis in nasopharyngeal carcinoma

被引:13
作者
Fei, Qian [1 ,2 ,3 ,5 ]
Du, Ming-Yu [1 ,2 ,3 ]
Qian, Lu-Xi [1 ,2 ,3 ,5 ]
Chen, Han-Bo [1 ,2 ,3 ,5 ]
Chen, Jie [4 ]
Zhu, Hong-Ming [1 ,2 ,3 ]
Tian, Xiao-Kang [4 ]
Jiang, Ning [1 ,2 ,3 ]
Gu, Jia-Jia [1 ,2 ,3 ]
He, Xia [1 ,2 ,3 ,5 ]
Yin, Li [1 ,2 ,3 ,5 ]
机构
[1] Nanjing Med Univ, Dept Radiat Oncol, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China
[2] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
[3] Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China
[4] Xuzhou Med Univ, Xuzhou, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Clin Sch 4, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
ADAM17; metastasis; miR-449b-3p; nasopharyngeal carcinoma; NF-kappa B; NF-KAPPA-B; THERAPEUTIC TARGET; ADAM17; MIGRATION; PROLIFERATION; RADIOTHERAPY; INFLAMMATION; MANAGEMENT; MICRORNAS; INVASION;
D O I
10.1002/cam4.2469
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An emerging body of evidence has promoted the understanding of the role of microRNAs (miRNAs) in tumorigenesis and progression, but the mediating function of miRNAs in nasopharyngeal carcinoma (NPC) development remains poorly elucidated. In this study, miR-449b-3p was downregulated in NPC specimens (P < .001) and cells (P < .05). Cytological and animal experiments provided evidence that miR-449b-3p inhibited NPC metastasis in vitro and in vivo. Disintegrin and metalloproteinase 17 (ADAM17) was revealed as a direct target of miR-449b-3p. Rescue experiments suggested that the downregulation of ADAM17 in the miR-449b-3p knockdown cells partially reversed the inhibition of cell invasion and migration. Luciferase reporter assay, chromatin immunoprecipitation assay, and Western blot analysis showed that ADAM17 could suppress the promoter activity and expression of miR-449b-3p by inducing NF-kappa B transcriptional activity. In conclusion, our study provided new insights into the underlying mechanism of the invasion and metastasis of NPC. The novel miR-449b-3p/ADAM17/NF-kappa B feedback loop could be a target for the clinical treatment of NPC.
引用
收藏
页码:6049 / 6063
页数:15
相关论文
共 35 条
[1]   ADAM17 as a Therapeutic Target in Multiple Diseases [J].
Arribas, Joaquin ;
Esselens, Cary .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (20) :2319-2335
[2]   Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomes mediates angiogenesis by repressing a novel target gene TSGA10 [J].
Bao, Lili ;
You, Bo ;
Shi, Si ;
Shan, Ying ;
Zhang, Qicheng ;
Yue, Huijun ;
Zhang, Jie ;
Zhang, Wei ;
Shi, Yunwei ;
Liu, Yifei ;
Wang, Xin ;
Liu, Dong ;
You, Yiwen .
ONCOGENE, 2018, 37 (21) :2873-2889
[3]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[4]   Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma [J].
Bissey, Pierre-Antoine ;
Law, Jacqueline H. ;
Bruce, Jeff P. ;
Shi, Wei ;
Renoult, Aline ;
Chua, Melvin L. K. ;
Yip, Kenneth W. ;
Liu, Fei-Fei .
ONCOGENESIS, 2018, 7
[5]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[6]   miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non-Small Cell Lung Cancer [J].
Cai, Junchao ;
Fang, Lishan ;
Huang, Yongbo ;
Li, Rong ;
Yuan, Jie ;
Yang, Yi ;
Zhu, Xun ;
Chen, Baixue ;
Wu, Jueheng ;
Li, Mengfeng .
CANCER RESEARCH, 2013, 73 (17) :5402-5415
[7]   NF-κB addiction and its role in cancer: 'one size does not fit all' [J].
Chaturvedi, M. M. ;
Sung, B. ;
Yadav, V. R. ;
Kannappan, R. ;
Aggarwal, B. B. .
ONCOGENE, 2011, 30 (14) :1615-1630
[8]  
Chen JT, 2015, INT J CLIN EXP PATHO, V8, P10922
[9]   A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma [J].
Chen, Y. P. ;
Wang, Z. X. ;
Chen, L. ;
Liu, X. ;
Tang, L. L. ;
Mao, Y. P. ;
Li, W. F. ;
Lin, A. H. ;
Sun, Y. ;
Ma, J. .
ANNALS OF ONCOLOGY, 2015, 26 (01) :205-211
[10]   NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance [J].
Chiu, Ching-Feng ;
Chang, Yi-Wen ;
Kuo, Kuang-Tai ;
Shen, Yu-Shiuan ;
Liu, Chien-Ying ;
Yu, Yang-Hao ;
Cheng, Ching-Chia ;
Lee, Kang-Yun ;
Chen, Feng-Chi ;
Hsu, Min-Kung ;
Kuo, Tsang-Chih ;
Ma, Jui-Ti ;
Su, Jen-Liang .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (18) :E2526-E2535